Background illustration for clinical trials search

Paid Clinical Trials Edmond

Discover 573 paid clinical trials in Edmond, Oklahoma. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

for
Obesity or Overweight
Location: Oklahoma City OK, Chickasha OK, McKinney TX,
Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT07575399

Phase 3, Recruiting
Active & Responsive

Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus

for
Type II Diabetes Mellitus
Location: Oklahoma City OK, El Dorado KS, Newton KS,
Sponsor: Sun Pharmaceutical Industries Limited

Sex: All

Age: 18+

Code: NCT07282743

Phase 2, Recruiting
Active & Responsive

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

for
Alzheimer Disease
Location: Oklahoma City OK, Irving TX, DeSoto TX, Austin TX,
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Sex: All

Age: 55 - 70+

Code: NCT06585787

Phase 3, Recruiting
Active & Responsive

A Study of Suvorexant (MK-4305) for the Treatment of Insomnia Disorder in Participants With Opioid Use Disorder (MK-4305-098)

for
Insomnia
Location: Oklahoma City OK, DeSoto TX, Houston TX, Savannah GA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18 - 70

Code: NCT06655883

Phase 3, Recruiting
Active & Responsive

Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)

for
Schizophrenia
Location: Oklahoma City OK, Fort Worth TX, Bryant AR, Lincoln NE,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07379827

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease

for
Chronic Granulomatous Disease (CGD)
Location: Oklahoma City OK, Topeka KS, Little Rock AR,
Sponsor: Ensoma

Sex: All

Age: 0+

Code: NCT06605378

Recruiting
Active & Responsive

Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial

for
Lupus Nephritis
Location: Oklahoma City OK, Fort Worth TX, Atlanta GA,
Sponsor: NephroNet, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07225387

Recruiting
Active & Responsive

Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease

for
Primary Sjogren's Disease
Location: Oklahoma City OK, Allen TX, Fort Worth TX, Euless TX,
Sponsor: Vor Biopharma

Sex: All

Age: 18 - 70+

Code: NCT07404865

Phase 3, Recruiting
Active & Responsive

Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease

for
Systemic Lupus Erythematosus
Location: Oklahoma City OK, Atlanta GA, San Diego CA, Hershey PA,
Sponsor: NYU Langone Health

Sex: All

Age: 55+

Code: NCT05799378

Phase 3, Recruiting
Active & Responsive

Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study

for
Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation
Location: Oklahoma City OK, Dallas TX, Fort Worth TX,
Sponsor: Chris Goss

Sex: All

Age: 6+

Code: NCT05548283

Recruiting
Active & Responsive

The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs).

for
Intracranial Aneurysm
Location: Oklahoma City OK, Memphis TN, Englewood CO,
Sponsor: Medtronic Neurovascular Clinical Affairs

Sex: All

Age: 18 - 70+

Code: NCT02998229

Recruiting
Active & Responsive

Postnatal Exercise to Activate Baby's Brown Fat

for
Childhood Obesity Prevention, Childhood Obesity,
Location: Oklahoma City OK, Boston MA
Sponsor: Joslin Diabetes Center

Sex: Female

Age: 18 - 45

Code: NCT07467694

Recruiting
Active & Responsive

Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)

for
Optic Neuritis, Myelitis, Myelitis, Transverse
Location: Oklahoma City OK, Dallas TX, Jackson MS, Aurora CO,
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT07100990

Phase 3, Recruiting
Active & Responsive

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

for
Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma
Location: Oklahoma City OK, Springdale AR, Fayetteville AR,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT07198074

Phase 3, Recruiting
Active & Responsive

Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas

for
Metastatic Dedifferentiated Liposarcoma,
Location: Oklahoma City OK, Bellevue NE, Omaha NE, Houston TX,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06422806

Phase 3, Recruiting
Active & Responsive

Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial

for
Advanced Esophageal Adenocarcinoma,
Location: Oklahoma City OK, Lawton OK, Salina KS, Hays KS,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06203600

Phase 2, Phase 3, Recruiting
Active & Responsive

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

for
Castration Levels of Testosterone,
Location: Oklahoma City OK, Richardson TX, Joplin MO, Dallas TX,
Sponsor: SWOG Cancer Research Network

Sex: Male

Age: 18+

Code: NCT03678025

Phase 3, Recruiting
Active & Responsive

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

for
Clinical Stage III Cutaneous Melanoma AJCC v8,
Location: Oklahoma City OK, Little Rock AR, Bellevue NE, Omaha NE,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05136196

Phase 2, Recruiting
Active & Responsive

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

for
Recurrent Head and Neck Squamous Cell Carcinoma,
Location: Oklahoma City OK, Lawton OK, Little Rock AR, Omaha NE,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT04671667

Phase 2, Recruiting
Active & Responsive

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: Oklahoma City OK, Lawton OK, Salina KS, Hays KS,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06589804

Phase 3, Recruiting